Oliver Luxxe Assets »

Catalyst Pharmaceutical Partners shares owned by Oliver Luxxe Assets

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Oliver Luxxe Assets from 13F filings

Historical chart of Oliver Luxxe Assets investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Oliver Luxxe Assets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Oliver Luxxe Assets

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.5M 75k 19.70
2025-06-30 $1.5M 71k 21.70
2025-03-31 $1.7M 70k 24.25
2024-12-31 $676k 34k 19.88
2024-09-30 $676k 34k 19.88

More positions owned by Oliver Luxxe Assets

Spdr Gold Tr Gold Shs (GLD)
Alphabet Cap Stk Cl A (GOOGL)
Morgan Stanley Com New (MS)
Citigroup Com New (C)
Ge Aerospace Com New (GE)
3M Company (MMM)
Capital One Financial (COF)
Meta Platforms Cl A (META)
Ralph Lauren Corp Cl A (RL)
Ge Vernova (GEV)
Mueller Industries (MLI)
Abbvie (ABBV)
Philip Morris International (PM)
Amazon (AMZN)
Entergy Corporation (ETR)

View all positions for Oliver Luxxe Assets

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Morgan Stanley
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners